INVIZIUS LIMITEDActive
Key figures
Like most small UK companies, INVIZIUS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Filed accounts2025
| 2025 | |
|---|---|
| Cash at bank and in hand | 396,677 |
| Total assets | — |
| Total liabilities | — |
| Net assets / total equity | 730,028 |
| Average number of employees | 7 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company is the research and development of medical products that improve the healthcare outcomes of patients treated using extra-corporeal therapies, such as dialysis.
As described in the company's latest filed accounts.
Summary: INVIZIUS LIMITED
Company
INVIZIUS LIMITED is a private limited company registered with Companies House under company number SC586903. It was incorporated on 26 Jan 2018. Its status is active. The registered office is in Edinburgh (EH4). Its nature of business (SIC 2007) is manufacture of pharmaceutical preparations (21200), manufacture of medical and dental instruments and supplies (32500).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £730,028. Cash at bank and in hand was £396,677. The company had an average of 7 employees.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 8 Feb 2027.